Skip to content
Governance Register
Sign inFind yourself
Find yourselfSign in
Search How it works For organisations For professionals

Edition

United KingdomIrelandUnited States (current)New ZealandCanadaAustraliaScotlandNorthern Ireland

← US public companies

Wolff Henry Ward

SEC-identified person · CIK 1302390 Identifier-verified

Public-company roles (from insider filings)

CompanyCapacity as filedFilings
Calithera Biosciences, Inc. CALA Director filed 2014 - 2022
Portola Pharmaceuticals INC PTLA Director filed 2013 - 2020
Viracta Therapeutics, Inc. VIRX Director filed 2018 - 2020
Sangamo Therapeutics, INC SGMO Director · Executive VP and CFO filed 2006 - 2016
MAP Pharmaceuticals, Inc. MAPP Director filed 2008 - 2013
Oruka Therapeutics, Inc. ORKA Sr. VP Finance and CFO filed 2006 - 2007
Abgenix INC ABGX CFO & SVP, Finance filed 2006 - 2006

All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.